Yüklüyor......
Unboosted versus boosted atazanavir for reducing morbidity and mortality in people with HIV/AIDS
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine whether unboosted atazanavir‐containing regimens are more effective and safe than boosted atazanavir‐containing regimens in reducing morbidity and mortality in people living with HIV/AIDS.
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491095/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005418.pub3 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|